{
  "created_at": "Sun Jul 10 20:12:13 +0000 2022",
  "id": 1546225802932633606,
  "id_str": "1546225802932633606",
  "full_text": "\ud83d\udde3O Minist\u00e9rio da Sa\u00fade decide n\u00e3o incorporar ao SUS, o primeiro medicamento preventivo \u00e0 Covid-19 para pacientes imunossuprimidos: Cilgavimabe + Tixagevimabe (Evusheld). Voc\u00ea concorda com isso? responda aqui \ud83d\udcf2https://t.co/Y3D7SsyZ5c\n\n.\n.\n..\n #evusheld #consultapublica https://t.co/cEJLfU8DxB",
  "truncated": false,
  "display_text_range": [
    0,
    268
  ],
  "entities": {
    "hashtags": [
      {
        "text": "evusheld",
        "indices": [
          242,
          251
        ]
      },
      {
        "text": "consultapublica",
        "indices": [
          252,
          268
        ]
      }
    ],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/Y3D7SsyZ5c",
        "expanded_url": "https://4et.us/retmjt",
        "display_url": "4et.us/retmjt",
        "indices": [
          209,
          232
        ]
      }
    ],
    "media": [
      {
        "id": 1546225801183600641,
        "id_str": "1546225801183600641",
        "indices": [
          269,
          292
        ],
        "media_url": "http://pbs.twimg.com/media/FXVMLIYXoAE7NW6.jpg",
        "media_url_https": "https://pbs.twimg.com/media/FXVMLIYXoAE7NW6.jpg",
        "url": "https://t.co/cEJLfU8DxB",
        "display_url": "pic.twitter.com/cEJLfU8DxB",
        "expanded_url": "https://twitter.com/pryscilatorres/status/1546225802932633606/photo/1",
        "type": "photo",
        "sizes": {
          "thumb": {
            "w": 150,
            "h": 150,
            "resize": "crop"
          },
          "small": {
            "w": 680,
            "h": 680,
            "resize": "fit"
          },
          "medium": {
            "w": 1080,
            "h": 1080,
            "resize": "fit"
          },
          "large": {
            "w": 1080,
            "h": 1080,
            "resize": "fit"
          }
        }
      }
    ]
  },
  "extended_entities": {
    "media": [
      {
        "id": 1546225801183600641,
        "id_str": "1546225801183600641",
        "indices": [
          269,
          292
        ],
        "media_url": "http://pbs.twimg.com/media/FXVMLIYXoAE7NW6.jpg",
        "media_url_https": "https://pbs.twimg.com/media/FXVMLIYXoAE7NW6.jpg",
        "url": "https://t.co/cEJLfU8DxB",
        "display_url": "pic.twitter.com/cEJLfU8DxB",
        "expanded_url": "https://twitter.com/pryscilatorres/status/1546225802932633606/photo/1",
        "type": "photo",
        "sizes": {
          "thumb": {
            "w": 150,
            "h": 150,
            "resize": "crop"
          },
          "small": {
            "w": 680,
            "h": 680,
            "resize": "fit"
          },
          "medium": {
            "w": 1080,
            "h": 1080,
            "resize": "fit"
          },
          "large": {
            "w": 1080,
            "h": 1080,
            "resize": "fit"
          }
        }
      }
    ]
  },
  "metadata": {
    "iso_language_code": "pt",
    "result_type": "recent"
  },
  "source": "<a href=\"http://etus.com.br\" rel=\"nofollow\">Etus Brasil</a>",
  "in_reply_to_status_id": null,
  "in_reply_to_status_id_str": null,
  "in_reply_to_user_id": null,
  "in_reply_to_user_id_str": null,
  "in_reply_to_screen_name": null,
  "user": {
    "id": 66554182,
    "id_str": "66554182",
    "name": "Priscila Torres",
    "screen_name": "pryscilatorres",
    "location": "S\u00e3o Paulo, Brasil",
    "description": "Jornalista, autora do Blog Artrite Reumatoide, idealizadora do Grupo EncontrAR e Blogueiros da Sa\u00fade. Arthritis Consumer Experts \ud83d\udc49 Patient Advocate \ud83c\udde7\ud83c\uddf7",
    "url": "https://t.co/r7wgRe5A2F",
    "entities": {
      "url": {
        "urls": [
          {
            "url": "https://t.co/r7wgRe5A2F",
            "expanded_url": "http://www.artritereumatoide.blog.br",
            "display_url": "artritereumatoide.blog.br",
            "indices": [
              0,
              23
            ]
          }
        ]
      },
      "description": {
        "urls": []
      }
    },
    "protected": false,
    "followers_count": 1959,
    "friends_count": 2640,
    "listed_count": 11,
    "created_at": "Tue Aug 18 01:26:24 +0000 2009",
    "favourites_count": 1099,
    "utc_offset": null,
    "time_zone": null,
    "geo_enabled": true,
    "verified": false,
    "statuses_count": 33490,
    "lang": null,
    "contributors_enabled": false,
    "is_translator": false,
    "is_translation_enabled": false,
    "profile_background_color": "8F66FF",
    "profile_background_image_url": "http://abs.twimg.com/images/themes/theme11/bg.gif",
    "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme11/bg.gif",
    "profile_background_tile": false,
    "profile_image_url": "http://pbs.twimg.com/profile_images/1499358997278769152/mT0Rx4o0_normal.jpg",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1499358997278769152/mT0Rx4o0_normal.jpg",
    "profile_banner_url": "https://pbs.twimg.com/profile_banners/66554182/1523545785",
    "profile_link_color": "B40B43",
    "profile_sidebar_border_color": "B333CC",
    "profile_sidebar_fill_color": "E34FCD",
    "profile_text_color": "0D0C0C",
    "profile_use_background_image": true,
    "has_extended_profile": true,
    "default_profile": false,
    "default_profile_image": false,
    "following": false,
    "follow_request_sent": false,
    "notifications": false,
    "translator_type": "none",
    "withheld_in_countries": []
  },
  "geo": null,
  "coordinates": null,
  "place": null,
  "contributors": null,
  "is_quote_status": false,
  "retweet_count": 0,
  "favorite_count": 0,
  "favorited": false,
  "retweeted": false,
  "possibly_sensitive": false,
  "lang": "pt",
  "text_tratado": "o ministerio da saude decide nao incorporar ao sus, o primeiro medicamento preventivo a covid  para pacientes imunossuprimidos: cilgavimabe + tixagevimabe (evusheld). voce concorda com isso? responda aqui https://t.co/ \n\n.\n.\n..\n #evusheld #consultapublica https://t.co/ ",
  "idioma": "pt",
  "texto_en": "(Talking head) The Ministry of Health decides not to incorporate into SUS, the first preventive drug to covid constant_numerica for immunosuppressed patients: cilgavimab + tixagevimab (evusheld). do you agree with that? answer here (mobile with arrow)https://t.co/constant_alfanumerica\n\n.\n.\n..\n #evusheld #consultapublica https://t.co/constant_alfanumerica",
